Immunocore
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $84,052 | $80,248 | $75,400 | $70,502 |
Gross Profit | 83,722 | 79,800 | 73,693 | 70,256 |
EBITDA | -15,274 | -8,502 | -16,017 | -20,191 |
EBIT | -16,440 | -9,537 | -17,009 | -21,202 |
Net Income | -23,771 | 8,736 | -11,616 | -24,436 |
Net Change In Cash | 84,052 | 80,248 | 75,400 | 70,502 |
Free Cash Flow | -17,535 | 20,299 | 23,141 | -5,017 |
Cash | 455,731 | 537,767 | 504,985 | 832,821 |
Basic Shares | 50,046 | 52,808 | 50,014 | 49,877 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $310,202 | $249,428 | $143,737 | $26,520 |
Gross Profit | 307,471 | 248,391 | 143,283 | -46,706 |
EBITDA | -70,461 | -51,646 | -38,354 | -166,715 |
EBIT | -71,781 | -55,736 | -43,689 | -174,306 |
Net Income | -51,087 | -55,287 | -41,224 | -131,523 |
Net Change In Cash | 310,202 | 249,428 | 143,737 | 26,520 |
Free Cash Flow | 20,888 | -2,485 | -33,466 | -130,757 |
Cash | 455,731 | 442,626 | 332,539 | 237,886 |
Basic Shares | 49,991 | 48,888 | 45,714 | 43,862 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.49 |
2024-12-31 | -$0.37 |
2024-09-30 | $0.17 |
2024-06-30 | -$0.23 |
